Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
Clinical trial NCT03033524 · COMPLETED
Trial details
- NCT number
- NCT03033524
- Sponsor
- PharmAbcine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-04
- Primary completion
- 2017-06-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.